US Physical Therapy Inc

US Physical Therapy Inc (USPH) Stock Analysis

$78.630

-0.464 (-0.59%)At close

Loading chart…
High
80.360
Open
79.730
VWAP
79.06
Vol
98.77K
Mkt Cap
1.40B
Low
78.180
Amount
7.81M
EV/EBITDA, TTM
12.48

U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 795 outpatient physical therapy clinics in 45 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers.

www.usph.com

AI analysis of US Physical Therapy Inc (USPH)

hold

US Physical Therapy Inc is currently a hold. The stock is priced at $78.63, which is below the analyst price target of $90 to $98, indicating potential upside. However, the recent earnings miss with a GAAP EPS of $0.25, which was $0.53 below expectations, raises concerns about profitability. Additionally, the RSI is at 50.37, suggesting the stock is neither overbought nor oversold, which supports a hold position. The main risk is the company's net income, which turned negative in Q4 2025 and Q1 2026, highlighting profitability challenges that could affect future performance.

Analyst Ratings (7)

+29.09% upside
Hold
2 Buy
5 Hold
0 Sell
Current: 78.63
Low
100.00
Average
101.50
High
103.00

Barrington

2026-08-10

Price Target

$98

Outperform

Barrington

2026-05-13

Price Target

$90

Outperform

Citizens

2026-05-08

Price Target

$98

Outperform

Jefferies

2026-03-09

Price Target

$102

Buy

JPMorgan

2025-11-24

Price Target

$100

Overweight

Valuation Metrics

The current forward P/E ratio for US Physical Therapy Inc (USPH) is 28.49, compared to its 5-year average forward P/E of 33.13.

Forward P/E

Fair
5Y Average P/E
33.13
Current P/E
28.49
Overvalued
38.23
Undervalued
28.03

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
19.33
Current EV/EBITDA
12.48
Overvalued
22.59
Undervalued
16.07

Forward P/S

Undervalued
5Y Average P/S
1.98
Current P/S
1.30
Overvalued
2.44
Undervalued
1.51

Alphio AI Price Scenarios for USPH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%USPH

$100.54

Scenario price

B

Base

Base · 50%USPH

$97.38

Scenario price

B

Bear

Bear · 25%USPH

$95.30

Scenario price

Whales holding USPH

V

Virtus Investment Advisers, LLC

+ HoldingUSPH

+3.53%

3M Return

C

Copeland Capital Management, LLC

+ HoldingUSPH

-7.86%

3M Return

Events Timeline

2026-08-05 (ET)

16:30:00

USPH Reports Q2 Revenue of $214.1M, Beating Expectations

16:30:00

U.S. Physical Therapy Confirms FY26 Adjusted EBITDA Outlook of $102M-$106M

2026-07-02 (ET)

08:00:00

U.S. Physical Therapy Acquires 12-Clinic Practice, Holds 67% Stake

2026-05-06 (ET)

16:30:00

USPH Reaffirms 2026 EBITDA Guidance of $102M to $106M

16:30:00

Company Reports Q1 Revenue of $198.3M, Below Expectations

News

USPH FAQ — answered by Alphio AI

U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 795 outpatient physical therapy clinics in 45 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

US Physical Therapy Inc is currently a hold. The stock is priced at $78.63, which is below the analyst price target of $90 to $98, indicating potential upside. However, the recent earnings miss with a GAAP EPS of $0.25, which was $0.53 below expectations, raises concerns about profitability. Additionally, the RSI is at 50.37, suggesting the stock is neither overbought nor oversold, which supports a hold position. The main risk is the company's net income, which turned negative in Q4 2025 and Q1 2026, highlighting profitability challenges that could affect future performance.

7 analysts cover USPH: 2 rate it Buy, 5 Hold and 0 Sell. The average price target is 101.50.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started